|
|
|
|
|
|
Action of a phenazepam metabolite, 2-amino-5-bromo-2'-chlorobenzophenone, onglycine and nmda receptors of rat hippocampal pyramidal neurones
M. V. Kopanitsa
Ін-т фізіології ім. О. О. Богомольця НАН України, Київ
Abstract
Action of 2-amino-5-bromo-2'-chlorobenzophenone (ABPH),
a metabolite of phenazepam, on currents evoked by the
activation of glycine and glutamate NMDA receptors has
been investigated in enzymatically isolated hippocampal
rat pyramidal neurones. It is demonstrated that 3 - 10 μM
ABPH caused an inhibitory effect on glycine receptors
which was more prominent after pre-incubation with the
drug. Peak amplitude of NMDA receptor-mediated currents
was weakly potentiated after prolonged (4-6 min)
incubation with 10 μM ABPH. Thus, the effects of the
benzophenone metabolites should be taken into account
when analysing the action of phenazepam and other benzodiazepine
drugs.
References
- Андронати С.А., Авруцкий А.В., Богатский А.В., и др. Феназепам – К.: Наук. думка, 1982. – 288 с.
- Врублевский С.В., Валеев А.Е., Черневская Н.И. Метод быстрой смены тестирующих растворов при исследованиях изолированных клеток // Физиол. журн. – 1985. – 31, № 2. – С. 241 – 242.
- Копаниця М.В., Руденко О.П. Похідні N-заміщених 2-аміно-5-галогенбензофенонів прискорюють де- сенситизацію ГАМК-активованих струмів в ізо- льованих нейронах Пуркін’є щурів // Арх. клін. експерим. медицины. – 2002. – 11, № 1. – С. 22 – 25.
- Bond A.J., Hailey D.M., Lader M.H. Plasma concentrations of benzodiazepines // Br. J. Clin. Pharmacol. –1977. – 4, № 1. – P. 51 – 56.
- Kondratskaya E.L., Lishko P.V., Chatterjee S.S., Krishtal O.A. BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel // Neurochem. Int. – 2002. – 40, № 7. – P. 647 – 653.
- Kopanitsa M.V., Lambert, J.J. Modulation of GABAA receptors by 5-bromobenzophenone derivatives depends on the presence of ?-subunit. In: Abstr. 2nd Bogomoletz-Nencki Symposium «Intracellular Signalling in Excitable Cells»,1-3 September Kyiv. – 2002. – P. 9.
- Kopanitsa M.V., Yakubovska L.M., Rudenko O.P., Krishtal O.A. Modulation of GABAА receptor-mediated currents by benzophenone derivatives in isolated rat Purkinjeneurones // Neuropharmacology. – 2002. – 43, № 4. –P. 764 – 777.
- Kopanitsa M.V., Zhuk O.V., Zinkovsky V.G., Krishtal O.A. Modulation of GABAA receptor-mediated currents by phenazepam and its metabolites // Naunyn-Schmiede- bergs Arch. Pharmacol. – 2001. – 364 , № 1. – P. 1 – 8.
- 9. Olfson M., Pincus H.A. Use of benzodiazepines in the community // Arch. Intern. Med. – 1994. – 154, № 11. – P. 1235 – 1240.
- 10. Olivier H., Fitz-Gerald M.J., Babiak B. Benzodiazepines revisited // J. La. State. Med. Soc. – 1998. – 150, № 10. – P. 483 – 485.
- Olsen R.W., Tobin A.J. Molecular biology of GABAA receptors // FASEB J. – 1990. – 4, № 5. – P. 1469 – 1480.
- Turner D.M., Sapp D.W., Olsen R.W. The benzodiazepine/alcohol antagonist Ro 15-4513: binding to a GABAAreceptor subtype that is insensitive to diazepam // J. Phar-macol. Exp. Ther. – 1991. – 257, № 3. – P. 1236 – 1242.
|
|
|
|
|
|
|
© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.
|
|